Latest news with #PDT
The Irish Sun
21 hours ago
- Entertainment
- The Irish Sun
‘Critical' swap all Playstation users must make NOW to avoid losing money as huge feature shuts down forever
PLAYSTATION users are being urged to make a "critical" swap after the gaming giant dropped an important feature. 1 PlayStation's loyalty rewards scheme is fully ending on November 2, 2026 Credit: Getty The reward scheme has been a highlight for players over the last three years, with campaigns and purchases that offer points. It was designed as a way to bring communities of PlayStation players together through a loyalty programme that could help users be celebrated. Points are able to be accumulated through playing games, and be exchanged for Vice President at PlayStation, Grace Chen, said in a statement: "Since launching the program, we've learned a lot from evaluating the types of activities our players respond best to, and as a company, we are always evolving with player and industry trends. Read More Tech News "Through this evaluation, we have decided to refocus our efforts and will be winding down the current version of PlayStation Stars." PlayStation Stars features PlayStation Stars rewards scheme lets you earn points It first launched as a new loyalty scheme for PlayStation games in Asia on September 29, 2022 Once you join PlayStation Stars, you can earn rewards by completing "campaigns and activities". It's completely free to join, and additional points can be earned when purchases are made on the PlayStation store You can swap those points for PlayStation Store credit PlayStation Store credit can be spent to buy games You can redeem points and claim PSN wallet funds or select PlayStation Store products. Changes to the loyalty programme PlayStation Stars is closing down, and is no longer accepting new members for this version of the programme Current PlayStation Stars members can still earn Digital Collectibles, Points and level up their status until July 23, 2025 at 7:59AM PDT | 3:59PM BST | 11:59PM JST. After this date, there will be no new PlayStation Stars Campaigns available, or any additional rewards or status benefits to earn. Qualifying Points are redeemable until November 2026 This version of the PlayStation Stars program will fully end on November 2, 2026 and current PlayStation Stars members can continue to redeem Points as long as their Points don't expire before then Your points will disappear on November 2, 2026 If you cancel PlayStation Stars today, you can't rejoin and you also lose your points The statement continued: "We want to thank all of our players for supporting PlayStation Stars since the launch in 2022. Most read in Tech "As we explore new ways to evolve our loyalty program efforts for the future, we'll continue to celebrate all of our players through the various community activities we have planned." What users can do as the changes come A new campaign which is available to all players, and not just those subscribed to 'It's fun as hell' cheer PS5 owners after finding freebie inside consoles and say they 'sure felt stupid' for missing it It is for PlayStation Tournaments, and offers 25 points to players who compete in any Fans have been offering advise on Reddit about which games to play to snap up these points. There are a few options. 'Download EA SPORTS FC 25 SHOWCASE (which is free) and in the game hub select to participate in the tournament," one user noted. Another added: 'You also might be able to use NBA 2K25." Others have recommended playing Naraka Bladepoint due to being a good game to boot up and compete in. The points can be gained after accepting the campaign in the PlayStation app and completing the goal. This should be done before the game is started up. Points will be added within the app, and can be redeemed against the PSN store credit. This is likely to be one of PlayStation Stars' last campaigns, so users should get in quick to claim their credit voucher if already accumulated a good amount of points.
Cedar News
a day ago
- Business
- Cedar News
X Ads Update: Hashtag Usage to Be Discontinued Starting June 27
X Engineering: To enhance the overall experience on our platform, X Ads containing hashtags will no longer be served starting tomorrow, June 27 at 12:00 AM PDT. Ads and campaigns without hashtags will continue to run as usual.
Business Upturn
2 days ago
- Business
- Business Upturn
KOORUI Launches Multi-Model Monitor Lineup Globally, Strengthening Its Presence in Key Markets
NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) — KOORUI, a global monitor brand backed by HKC's panel expertise, has announced the global release of five new monitors: G2741L, G2411P, 34E6UC, 27E6CA, and E2412F. The launch spans a wide range of use cases—from high-refresh-rate gaming to immersive work displays and affordable everyday options—demonstrating KOORUI's ongoing effort to serve the evolving needs of users around the world. This new lineup reflects a thoughtful approach to product design. The G2411P cater to gamers with smooth 200Hz performance and vibrant visuals. The 34E6UC and 27E6CA feature curved displays and wide formats for enhanced productivity,while the slim and practical E2412F offers a reliable solution for efficient office work. *KOORUI's new releases level up your gaming with next-level power 'Every screen we make is designed with real usage in mind,' said a KOORUI marketing representative 'We believe technology should adapt to people's lives—not the other way around.' Global demand for monitors continues to grow, driven by hybrid work, online learning, and entertainment. By offering multiple models in one coordinated release, KOORUI aims to simplify choice while giving users across different regions access to well-balanced, purpose-driven products. While not part of a dedicated campaign, the timing of this launch aligns with Amazon Prime Day in the U.S., taking place from July 15 to 16 (PDT)—one of the most anticipated global shopping events. KOORUI will be participating with thoughtfully crafted pricing on select models, delivering surprising value without compromising on design, performance, or reliability. It marks an important step in KOORUI's journey toward greater global reach, with expanded availability across North America, Europe, and Southeast Asia. As KOORUI continues to grow, it remains focused on making quality display technology more accessible—one screen at a time. About KOORUI Powered by HKC's semiconductor display expertise, KOORUI blends innovative panel manufacturing with human-centered product design. Its monitor lineup empowers creators, gamers, and professionals around the globe with reliable, high-performance visual solutions. Press Contact: KOORUI PR Team Email: [email protected] Website:
Yahoo
3 days ago
- Business
- Yahoo
ADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today?
ADMA Biologics ADMA and Takeda TAK are leading players in the plasma derived immunoglobulin sector. ADMA markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases. On the other hand, Takeda has a well-diversified business with a focus on gastroenterology (GI), rare diseases, plasma-derived therapies (PDT), oncology and neuroscience. Given the companies' commanding position in the plasma-derived therapies market, choosing one stock over another can be challenging. Let us delve into their fundamentals, potential growth prospects, challenges and valuation levels to make a prudent choice. ADMA Biologics markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases. The company's top line currently comprises sales of three FDA-approved products — Bivigam (an Intravenous Immune Globulin ['IVIG'] product to treat primary humoral immunodeficiency), Asceniv (to treat primary immunodeficiency disease or PIDD) and Nabi-HB (to treat and provide enhanced immunity against the hepatitis B virus). Asceniv, its lead product, is a plasma-derived IVIG that contains naturally occurring polyclonal antibodies. These antibodies are proteins used by the body's immune system to neutralize microbes, such as bacteria and viruses, and prevent infections and diseases. Asceniv is indicated for the treatment of PIDD or inborn errors of immunity in adults and adolescents. It is manufactured using ADMA's unique, patented plasma donor screening methodology and tailored plasma pooling design, which blends normal source plasma with respiratory syncytial virus plasma obtained from donors tested using the company's proprietary microneutralization assay. Demand was record high in the first quarter. Consequently, ADMA expects Asceniv's total revenue share to expand throughout 2025 and beyond. ADMA plans to file a supplemental biologics license application in mid-2025 for the expansion of Asceniv's label to include the pediatric setting for patients who are two years and older. ADMA expects to generate initial, proof-of-concept animal data before 2025-end for its lead pipeline program, SG-001, a hyperimmune globulin targeting S. pneumonia. It believes that SG-001 has the potential to generate $300-500 million or more in high-margin annual revenues, with IP protection through at least 2037. Takeda is focused on developing life-saving plasma-derived therapies, which are essential for patients with a variety of rare and complex chronic diseases. Takeda has created a dedicated PDT business unit that manages the business end-to-end, from plasma donation to manufacturing, R&D and commercialization. The PDT business posted 9% growth in 2024. Takeda's broad immunoglobulin portfolio includes Hyqvia, Cuvitru, Gammagard Liquid and Gammagard S/D. Among these, Hyqvia is a product consisting of human normal IG and recombinant human hyaluronidase (licensed from Halozyme). Hyqvia is the only subcutaneous IG treatment for primary immunodeficiencies (PID) patients with a dosing regimen that requires only one infusion up to once per month and one injection site per infusion to deliver a full therapeutic dose of IG. It is approved in the United States for adults with PID, and in Europe for patients with PID syndromes and myeloma or CLL with severe secondary hypogammaglobulinemia and recurrent infections. Hyqvia was also approved for maintenance treatment in adult patients with chronic inflammatory demyelinating polyneuropathy (CIDP) in the United States and CIDP patients of all ages in Europe. Gammagard Liquid/Kiovig is a liquid formulation of the antibody replacement therapy immunoglobulin (IG), for the treatment of adult and pediatric patients two years of age or older with PID and adult patients with multifocal motor neuropathy (MMN) (administered intravenously). It is also approved for adult patients with CIDP. Kiovig is the brand name used for Gammagard Liquid in many countries outside the United States. Cuvitru is indicated as replacement therapy for primary humoral immunodeficiency in adults and pediatric patients two years of age and older. The PDT business is one of the focal areas for Takeda's R&D efforts. The company is developing next-generation immunoglobulin products with 20% facilitated SCIG (TAK-881) and liquid low IgA IG (TAK-880). It is also pursuing other early-stage opportunities (e.g., hypersialylated Immunoglobulin [hsIgG]) that would diversify its portfolio further. The company has also joined forces with Halozyme, Kamada, and Johnson & Johnson to advance its pipeline further. The Zacks Consensus Estimate for ADMA's 2025 sales implies a year-over-year increase of 18.61%, and that for earnings per share (EPS) suggests an improvement of 36.73%. However, EPS estimates for 2025 have moved south in the past 60 days. Nonetheless, the metric for 2026 has moved north during the same time frame. Image Source: Zacks Investment Research The Zacks Consensus Estimate for TAK's 2025 sales implies a year-over-year decrease of 2.80%, while that for EPS suggests an improvement of 6.21%. However, EPS estimates for 2025 and 2026 have moved south in the past 60 days. Image Source: Zacks Investment Research From the perspective of price performance, TAK has fetched better returns than ADMA so far this year. Shares of ADMA have gained 4.1%, while those of TAK have risen 13.91%. Image Source: Zacks Investment Research From a valuation standpoint, ADMA is more expensive than TAK. ADMA's shares currently trade at 21.79X forward earnings, higher than 9.03X for TAK. Image Source: Zacks Investment Research Large biotech companies are generally considered safe havens for investors interested in this sector. Takeda is a drug giant with an extremely broad and diverse portfolio. It is one of the three largest producers of plasma derivatives in terms of total sales. TAK's diversified plasma drug portfolio, global infrastructure, and encouraging R&D efforts should help it drive growth in its PDT business. TAK currently carries a Zacks Rank #4 (Sell). On the other hand, ADMA's top line is witnessing steady growth on the back of robust Asceniv demand. An acceleration in new patient starts, a potential label expansion and further penetration in existing markets should significantly expand Asceniv's sales. ADMA currently carries a Zacks #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. While large-cap TAK provides stability and has provided better returns than ADMA so far this year, we believe ADMA's revenue potential to be further unlocked with the market expansion of Asceniv, positioning it for solid growth. Hence, ADMA is a better pick at present. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ADMA Biologics Inc (ADMA) : Free Stock Analysis Report Takeda Pharmaceutical Co. (TAK) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Daily Mirror
3 days ago
- Entertainment
- Daily Mirror
Fortnite Squid Game skins price, every cosmetic and how to get Twitch Drops
A new collection of Fortnite Squid Game skins have arrived in the game, and there's a way to unlock some of the free items through Twitch Drops – here's how you can get them. A fresh batch of Fortnite Squid Game skins have landed in Fortnite, marking the Netflix series' takeover of the Reload mode. The collaboration between Fortnite and Squid Game has kicked off, with the game ramping up its crossover efforts. Since unveiling the series' presence in Fortnite's UEFN tools, players have been intrigued about what lies ahead for Squid Game 's role in the Battle Royale title, and it appears there's plenty in store. The guards and contestants from the show have made a grand entrance in a major new Fortnite Squid Game Reload takeover, transforming the Oasis map mode and introducing several new POIs entirely themed around the Netflix series. This is one of Fortnite 's most significant crossovers recently, but it doesn't stop at the revamped mode. A host of new cosmetics are being introduced to keep players hooked, both through purchases and Twitch Drops, even as many continue to progress through the Super season Battle Pass. So, how can you get your hands on all of them? Here's everything you need to know about the Fortnite Squid Game skins and cosmetics. Fortnite Squid Game Skins A new blog post has revealed that a massive collection of Squid Game skins will be available in the game from Tuesday, June 26 at 5pm PDT / 8pm EDT, and Wednesday, June 27 at 1am BST for UK players. The Fortnite Squid Game skins were announced by Fortnite in a blog post, with leakers like @ShiinaBR revealing their bundle prices in advance. They've stated that the full bundle will set you back 3,000 V-Bucks, while the accompanying Gear Bundle will cost an additional 700 V-Bucks. This means that if you're keen on acquiring all the cosmetics, you'll need to purchase a bundle of 5,000 V-Bucks (£27.99 / $36.99 / AU$47.95) starting from scratch. It's quite a hefty sum for the collection, but you'll have some V-Bucks to spare. Here's what's included in the Fortnite Squid Game skins drop in the Item Shop: Fortnite Squid Bundle Fortnite Squid Accessories Bundle Fortnite Squid Game Twitch Drops While the Fortnite Squid Game skins come with a price tag, Epic Games is offering some free cosmetics as part of a new Twitch Drops initiative to encourage Fortnite stream viewing. By watching any channel in the Fortnite category on Twitch between 6am PDT / 9am EDT / 2pm BST on Friday, June 27 and 8.59pm PDT / 11.59pm EDT on Sunday June 29, and 4.30am BST on Monday, June 30 for UK players, you can unlock emoticons and sprays. The following items can be earned: It's a lot to take in, but dive in early and you'll have the opportunity to snag some freebies as well as the brand new Fortnite Squid Games skins. You'll blend right in on the Squid Grounds.
